Strain engineering for bumping over IPs: Numerical investigations of thermo-mechanical stress induced mobility variations for CMOS 32nm and beyond

2013 ◽  
Vol 53 (2) ◽  
pp. 229-235 ◽  
Author(s):  
Vincent Fiori ◽  
Sébastien Gallois-Garreignot ◽  
Hervé Jaouen ◽  
Clément Tavernier
2009 ◽  
Vol 30 (7) ◽  
pp. 760-762 ◽  
Author(s):  
Kyong Taek Lee ◽  
Chang Yong Kang ◽  
Min-Sang Park ◽  
Byoung Hun Lee ◽  
Ho Kyung Park ◽  
...  

2015 ◽  
Vol 55 (6) ◽  
pp. 980-989 ◽  
Author(s):  
Sébastien Gallois-Garreignot ◽  
Naceur Benzima ◽  
Etienne Benmussa ◽  
Caroline Moutin ◽  
Pierre-Olivier Bouchard ◽  
...  

2003 ◽  
Vol 112 ◽  
pp. 943-946 ◽  
Author(s):  
K. Koho ◽  
J. Vimpari ◽  
L. Straka ◽  
N. Lanska ◽  
O. Sôderberg ◽  
...  
Keyword(s):  

1977 ◽  
Vol 37 (02) ◽  
pp. 329-338 ◽  
Author(s):  
Tadahiro Sano ◽  
Takeshi Motomiya ◽  
Hiroh Yamazaki ◽  
Takio Shimamoto

SummaryA new method for assessment of platelet sensitivity to ADP-aggregation was devised. Its reproducibility and the correlations between the values obtained by this method, the optical density (O. D.) method, and the screen filtration pressure (SFP) method were assessed. In summary, this method may be said to have three main points:1. It can be performed without centrifugation, avoiding mechanical stress to platelets, using only 0.8 ml. of blood and inexpensive equipment.2. It may reflect different aspects of platelet function from the O. D. method and the SFP method, despite the positive significant correlations between the values obtained by these three methods.3. It was proved to be highly reproducible and is thought to be useful clinically.By using this method, the effect of sustained isometric exercise by handgripping on platelet aggregability was assessed in coronary sclerotic and cerebral arteriosclerotic patients on placebo and EG-626, a newly synthesized cyclic AMP phosphodiesterase inhibitor. On placebo, an enhancement of platelet sensitivity was observed after isometric exercise in coronary and cerebral arteriosclerotic patients but not in healthy control subjects. The enhancement was prevented by pretreatment of EG-626, administered orally 1.5 hours prior to exercise.


CIM Journal ◽  
2017 ◽  
Vol 8 (1) ◽  
Author(s):  
E. Kucukal ◽  
J. R. Kadambi ◽  
J. Furlan ◽  
R. Visintainer

2006 ◽  
Vol 16 (8) ◽  
pp. 981-996 ◽  
Author(s):  
Richard A. Jepsen ◽  
Sam S. Yoon ◽  
Byron Demosthenous

Sign in / Sign up

Export Citation Format

Share Document